CEL-SCI CVM Stock
CEL-SCI Price Chart
CEL-SCI CVM Financial and Trading Overview
| CEL-SCI stock price | 1.48 USD |
| Previous Close | 1.54 USD |
| Open | 1.52 USD |
| Bid | 1.47 USD x 90000 |
| Ask | 1.5 USD x 50000 |
| Day's Range | 1.44 - 1.59 USD |
| 52 Week Range | 0.89 - 13.48 USD |
| Volume | 249.26K USD |
| Avg. Volume | 333.25K USD |
| Market Cap | 21.45M USD |
| Beta (5Y Monthly) | 0.711 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.15 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | August 28, 1996 |
| 1y Target Est | N/A |
CVM Valuation Measures
| Enterprise Value | 19.18M USD |
| Trailing P/E | N/A |
| Forward P/E | -1.6086956 |
| PEG Ratio (5 yr expected) | 1.12 |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 1.829419 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.951 |
Trading Information
CEL-SCI Stock Price History
| Beta (5Y Monthly) | 0.711 |
| 52-Week Change | -38.33% |
| S&P500 52-Week Change | 27.29% |
| 52 Week High | 13.48 USD |
| 52 Week Low | 0.89 USD |
| 50-Day Moving Average | 2.79 USD |
| 200-Day Moving Average | 5.94 USD |
CVM Share Statistics
| Avg. Volume (3 month) | 333.25K USD |
| Avg. Daily Volume (10-Days) | 458.32K USD |
| Shares Outstanding | 14.49M |
| Float | 8.17M |
| Short Ratio | 0.39 |
| % Held by Insiders | 5.45% |
| % Held by Institutions | 5.36% |
| Shares Short | 255.03K |
| Short % of Float | 1.77% |
| Short % of Shares Outstanding | 1.76% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:30 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | September 30, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | September 30, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -70.28% |
| Return on Equity (ttm) | -305.27% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -14886794 USD |
| EBITDA | -20176348 USD |
| Net Income Avi to Common (ttm) | -22700800 USD |
| Diluted EPS (ttm) | -2.15 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.9M USD |
| Total Cash Per Share (mrq) | 0.22 USD |
| Total Debt (mrq) | 8.51M USD |
| Total Debt/Equity (mrq) | 123.82 USD |
| Current Ratio (mrq) | 0.602 |
| Book Value Per Share (mrq) | 0.809 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -16654679 USD |
| Levered Free Cash Flow (ttm) | -9230027 USD |
Profile of CEL-SCI
| Country | United States |
| State | VA |
| City | Vienna |
| Address | 8229 Boone Boulevard |
| ZIP | 22182 |
| Phone | 703 506 9460 |
| Website | https://cel-sci.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
CEL-SCI Corporation, a clinical-stage biotechnology company, engages in the research and development to treat cancer and other diseases by using the immune system in the United States. The company's lead immunotherapy is Multikine, which has completed Phase III clinical trials for the potential treatment of certain head and neck cancers. It is also developing Ligand Epitope Antigen Presentation System (LEAPS) technology, a patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, parasitic infections, autoimmune conditions, allergies, transplantation rejections, and cancer, as well as to potentially treat rheumatoid arthritis. In addition, the company's LEAP product candidates include CEL-2000; CEL-4000; and CEL-5000 that are in preclinical trials for potential rheumatoid arthritis therapeutic treatments. CEL-SCI Corporation has a strategic partnership with Saudi Arabian Pharma Company for Multikine in the treatment of head and neck cancer. The company was incorporated in 1983 and is headquartered in Vienna, Virginia.
Q&A For CEL-SCI Stock
What is a current CVM stock price?
CEL-SCI CVM stock price today per share is 1.48 USD.
How to purchase CEL-SCI stock?
You can buy CVM shares on the NYSE American exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for CEL-SCI?
The stock symbol or ticker of CEL-SCI is CVM.
Which industry does the CEL-SCI company belong to?
The CEL-SCI industry is Biotechnology.
How many shares does CEL-SCI have in circulation?
The max supply of CEL-SCI shares is 14.49M.
What is CEL-SCI Price to Earnings Ratio (PE Ratio)?
CEL-SCI PE Ratio is now.
What was CEL-SCI earnings per share over the trailing 12 months (TTM)?
CEL-SCI EPS is -2.15 USD over the trailing 12 months.
Which sector does the CEL-SCI company belong to?
The CEL-SCI sector is Healthcare.
CEL-SCI CVM included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NYSE American Composite Index XAX | 8750.58 USD — |
-0.14
|
— — | 8749.41 USD — | 8844.17 USD — | — - | — — |
- {{ link.label }} {{link}}